Search details
1.
Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes.
Subst Abus
; 42(4): 506-511, 2021.
Article
in English
| MEDLINE | ID: mdl-33945452
2.
Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs.
CNS Spectr
; 24(3): 287-312, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30295215
3.
A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.
J Public Health Manag Pract
; 24(4): 310-317, 2018.
Article
in English
| MEDLINE | ID: mdl-29084123
4.
Combined Gabapentinoid and Opioid Use.
Ann Intern Med
; 170(12): 908-909, 2019 06 18.
Article
in English
| MEDLINE | ID: mdl-31207628
5.
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment.
J Addict Med
; 17(2): 227-229, 2023.
Article
in English
| MEDLINE | ID: mdl-36074787
6.
Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse.
Res Social Adm Pharm
; 19(4): 599-609, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36503683
7.
State-level response to gabapentin misuse in the United States: Implications and future direction.
Am J Health Syst Pharm
; 79(9): e143-e148, 2022 04 19.
Article
in English
| MEDLINE | ID: mdl-34951456
8.
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach.
J Addict Med
; 16(4): 399-406, 2022.
Article
in English
| MEDLINE | ID: mdl-34954746
9.
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states.
Drug Alcohol Depend
; 237: 109518, 2022 08 01.
Article
in English
| MEDLINE | ID: mdl-35691255
10.
Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series.
J Subst Abuse Treat
; 126: 108316, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34116808
11.
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
J Clin Pharmacol
; 61 Suppl 2: S89-S99, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34396549
12.
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids.
Ment Health Clin
; 11(4): 225-230, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34316417
13.
Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
Int J Clin Pharm
; 43(4): 1055-1064, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33387188
14.
Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
Drugs
; 81(1): 125-156, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33215352
15.
Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Clin Drug Investig
; 41(3): 245-253, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33580482
16.
Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts.
J Subst Abuse Treat
; 131: 108416, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34098294
17.
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
Am J Health Syst Pharm
; 78(7): 613-618, 2021 03 18.
Article
in English
| MEDLINE | ID: mdl-33411894
18.
Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative Review.
Open Forum Infect Dis
; 7(11): ofaa503, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-33241069
19.
Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race.
J Atten Disord
; 24(1): 10-19, 2020 01.
Article
in English
| MEDLINE | ID: mdl-28152660
20.
Prevalence and characteristics of self-reported kratom use in a representative US general population sample.
J Addict Dis
; 38(4): 506-513, 2020.
Article
in English
| MEDLINE | ID: mdl-32657217